“…Lately, however, it has been suggested that sense controls do not provide any additional advantage over nonsense ODNs, especially because any potentially critical sequence motifs (recurring sequences of 3-8 bases in the mRNA) that may contribute to the structure or function of the targeted mRNA are lost (Stein, 1999). In addition, sense ODNs are known to produce nonspecific effects (Helene and Toulme, 1990;Nicot and Pfaff, 1997;Kalra and Kalra, 2000), including inhibition of the targeted protein (Georgieva et al, 1995), and therefore, several recent studies (in vivo and in vitro) have not used the sense control (Turchi and Sarter, 2001;Clayton et al, 2002;Frantseva et al, 2002;Grimpe et al, 2002;Torner et al, 2002). There also appears to be agreement that demonstration of antisense-induced suppression of the desired protein without any neurotoxicity and reversal of the behavioral changes after termination of antisense administration are essential to ascertain the efficacy and specificity of antisense (Nicot and Pfaff, 1997;Stein, 1999Stein, , 2001).…”